11 – 20 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Plasma Biomarkers for Clinical Assessment of Bone Mineral Density in Heart Transplanted Patients—A Single-Center Study at Skåne University Hospital in Lund
(
- Contribution to journal › Article
-
Mark
Data on plasma tumour and metabolism related proteins’ potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension
(
- Contribution to journal › Article
- 2021
-
Mark
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2020
-
Mark
Elevated plasma sRAGE and IGFBP7 in heart failure decrease after heart transplantation in association with haemodynamics
(
- Contribution to journal › Article
-
Mark
Prolargin and matrix metalloproteinase-2 in heart failure after heart transplantation and their association with haemodynamics
(
- Contribution to journal › Article
-
Mark
Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics
(
- Contribution to journal › Article
-
Mark
Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics
(
- Contribution to journal › Article